Home Influence of Siluron® insertion on model drug distribution in the simulated vitreous body
Article Open Access

Influence of Siluron® insertion on model drug distribution in the simulated vitreous body

  • Sandra Stein , Malte Bogdahn , Werner Weitschies and Anne Seidlitz EMAIL logo
Published/Copyright: September 30, 2016

Abstract

Biorelevant in vitro test systems may be helpful to understand the in vivo behaviour of modern intravitreal dosage forms such as implants and injections. The already presented Vitreous Model (VM) in combination with the Eye Movement System (EyeMoS) was used to simulate the situation after a vitrectomy in combination with Siluron® silicone oil (SO) insertion in vitro and to investigate the distribution of the model drug fluorescein sodium (FS) within the modified VM. The state after a vitrectomy was simulated in vitro by replacing half the volume of the gelled vitreous substitute by SO. Under consideration of simulated eye movements the position of SO towards the simulated vitreous body was examined. Furthermore, the influence of two different injection techniques was studied. On the one hand, FS was injected directly into the gel and on the other hand the injection was set through the gel in order to directly reach the SO. Independent of the injection technique, it was shown that the model drug distributed almost exclusively into the gel and not into the SO. This can be explained with the backflow of FS into the gel and the lack of solubility in the SO. Using the modified VM and EyeMoS, the in vitro characterization of drug release and distribution behaviour of intravitreal injections can be performed under consideration of a simulated vitrectomy.

1 Introduction

The use of Siluron® silicone oil (SO) as an intraocular tamponade has become a standard technique in vitreoretinal surgeries [1], [2]. Pathological changes of the vitreous due to retinal detachment, diabetic retinopathy or vitreous haemorrhage may require the partial removal of the vitreous body. Subsequently, SO serves as an internal tamponade to retinal holes, stabilizes the intraocular pressure and prevents a further retinal detachment by pressing the retina onto the pigment epithelium.

There is a lack of data about the behaviour of SO within the vitrectomized eye especially in combination with drug administration. A reliable tamponade effect acting on the retina is expected if the SO is located close to the target tissue. The effectiveness of this procedure is considered to depend on the shape, volume, weight and position of the SO bubble. Also, patients that have undergone vitrectomy and SO insertion are often treated with intravitreal drug injections. It is unclear how this exchange of the vitreous body against SO affects the local drug concentrations and the pharmacokinetics within the eye.

To gain a better understanding of the circumstances within vitrectomized eyes, an in vitro model was developed. This model consists of the previously developed and slightly modified combination of the Vitreous Model (VM [3]) and the Eye Movement System (EyeMoS [4]) with a partial substitution of the simulated vitreous against Siluron®.

2 Material and methods

2.1 Preparation of the simulated vitreous body

The conventional VM of glass [3] was combined with a new 3D printed VM (see Figure 1) in order to examine both quantitatively and visually distribution behaviour of the fluorescent model drug within the simulated vitreous body. The 3D printed part of the VM is made of black polylactide (PLA, 2.85 mm Innofil3D) and equipped with two medical injection ports (IN-Stopper, BBraun, Melsungen, Germany) to ensure the repeatability of the injection position. All 3D printed devices were created using the open source parametric 3D CAD modeler (FreeCAD), the slicing software Cura 15.04 and the 3D printer Ultimaker 2 (iGo3D GmbH, Hannover, Germany).

Figure 1 Schematic view of the modified 3D printed Vitreous Model. Fluorescein sodium was either injected directly into the polyacrylamide gel (A) or through the polyacrylamide gel into silicone oil (B).
Figure 1

Schematic view of the modified 3D printed Vitreous Model. Fluorescein sodium was either injected directly into the polyacrylamide gel (A) or through the polyacrylamide gel into silicone oil (B).

In this in vitro study a modified polyacrylamide gel (PAAG) served as synthetic vitreous substitute [3]. The hydrogel consists of Rotiphorese®, ammoniumperoxo-disulfate (APS) and tetramethylethylenediamine (TEMED®). All chemicals were of analytical grade and purchased from Carl Roth GmbH (Karlsruhe, Germany). The polyacrylamide, being in a liquid state, was filled into the VM. After gelation, the model was filled with silicone oil resulting in a ratio 50:50, v/v of gel:SO. Siluron® 5000 (FLUORON GmbH, Ulm, Germany), a high purity sterilized liquid, composed of repetitive polydimethylsiloxane units (CH3)3SiO-[Si(CH3)2O]nSi(CH3)3 was used for this purpose. It is a certified transparent medical device for intraocular use. The physicochemical properties of Siluron® 5000 in comparison to the natural vitreous body and the PAAG are shown in Table 1.

Table 1

Comparison of the physicochemical properties of the natural vitreous body, polyacrylamide gel and Siluron® 5000.

PropertyHuman/ porcine vitreous body [3]Polyacryl-amide gel [3]Siluron® 5000 [5]
Density at 25 °C (g/cm3)1.0053–1.00891.0013 ± 0.00140.97
Refractive index1.3345–1.33481.33851.404
Miscibility with watermisciblemiscibleimmiscible
Table 2

Movement schemes for the in vitro simulation of human eye movements.

Movement schemes (x-axis)Angle (°)Angular velocity (°/s)
1Slow pursuit movement3541
2Fast pursuit movement3383
3Saccadic movement42165
4Circular movement with distinct amplitudes90330
Movement scheme (y-axis)2060
Table 3

Movement schemes for the investigation periods of 1, 4, 8, 24 and 48 h.

Time of investigation (h)Programmed movement scheme, Modus (color code) and duration (min)
1101101101101106
44514514514514511
8Two runs of the 4 h experiment
2429052805260530052855
48Two runs of the 24 h experiment

2.2 In vitro distribution testing

The EyeMoS [4] has been designed to integrate the established VM and to simulate human eye movements in vitro. It is composed of six 3D printed holders, in which six VM can be clamped. With the software Nanopro 1.70.8.0, two multiphase motors (PD4 N6018L4204, Nanotec Electronic GmbH & Co. KG, Feldkirchen near Munich, Germany) were programmed to implement four different movement patterns (see Figure 1) and to combine them together (see Figure 1) to more adequately simulated movement patterns.

An aqueous solution of fluorescein sodium (FS, 2 mg/ml, injection volume of 20 μl) was injected via the IN-Stopper. A subject of investigation was the distribution of FS after a central injection into the PAAG (22 G needle). In another set of experiments, the injection spot was located in the half of the model occupied by the SO thus injecting through the PAAG (see Figure 1).

After a movement activity of 1, 4, 8, 24 and 48 h the VM was removed from the EyeMoS and deep-frozen (−19°C). Since the SO did not freeze opposed to the PAAG, both phases were separated, incubated with 4 ml modified Ringer buffer solution and analysed by fluorescence spectrometry (Varioskan Flash, Thermo Scientific, Waltham, USA) with an excitation wave length of 485 nm and an emission wave length of 538 nm.

3 Results and discussion

3.1 Simulation of vitrectomized vitreous bodies

By the use of the modified VM with a partial replacement of PAAG by SO as substitute (50:50, v/v), an in vitro model of the vitrectomized eye was successfully implemented.

In vivo, a reliable tamponade effect is expected if the SO is located close to the retina and is not dislocated during eye movement. During the period of 72 h with simulated eye movements, the positions of SO and PAAG in the simulated vitrectomized eye did not change. Neither fast nor slow simulated eye movements caused a change in the shape and size of the SO bubble. There was no phase distribution or formation of droplets. This finding is in accordance with the results obtained by Hillier et al. [6] who also investigated the behaviour of SO in simulated vitreous in vitro.

A limitation of the presented in vitro system is the missing of anatomical elements of the eye, for example the lens, which may influence the position and behaviour of the SO. However, the model allows for first experiments regarding the distribution of injected drug between the two compartments (simulated vitreous and SO).

3.2 In vitro distribution testing

The fluorescent model drug was chosen to visually track the distribution in the simulated vitreous body. After the injection of FS into the PAAG, the already described injection channel [3], [7] was still detectable in vitro. Within 1 h of simulated eye movement, FS diffused from the clearly defined injection channel to peripheral regions of PAAG (see Figure 2A). An optically homogeneous distribution of FS within the PAAG was found after nearly 24 h (see Figure 2C). There was no distribution of FS into the SO. FS was only detected to a remarkable extent within the gel phase (see Figure 3). The injection through PAAG into SO could not be conducted in the way as it was intended. The PAAG covered the tip of the injection needle dislocating the boundary between the gel and the SO with the needle movement. This effect may have been caused by the surface texture of the injection needle and the rheological properties of the PAAG as well as the SO. Therefore an injection through the PAAG directly into the SO was not feasible. The injection was performed at the same spot in spite of the dislocated boundary between the phases. During the injection of FS, the solution flowed back along the puncture duct and was distributed along the phase boundary between the PAAG and the SO. The examination of drug distribution after the injection through the PAAG into the SO lead to comparable results as the direct injection into the PAAG (see Figure 4). Almost all of the injected FS was distributed to the PAAG. The only difference was the initial spreading of FS at the interface of the PAAG and the SO instead of the injection channel when the injection was set directly into the PAAG.

Figure 2 Cross section through the frozen polyacrylamide gel. Visual distribution of fluorescein sodium in the simulated vitreous body after 1 h (A), 8 h (B) and 24 h (C).
Figure 2

Cross section through the frozen polyacrylamide gel. Visual distribution of fluorescein sodium in the simulated vitreous body after 1 h (A), 8 h (B) and 24 h (C).

Figure 3 Distribution of fluorescein sodium in the Vitreous Model after central injection into polyacrylamide gel. Experiments were performed with 3 Vitreous Models per time point.
Figure 3

Distribution of fluorescein sodium in the Vitreous Model after central injection into polyacrylamide gel. Experiments were performed with 3 Vitreous Models per time point.

Figure 4 Distribution of fluorescein sodium in the Vitreous Model after injection through polyacrylamide gel into silicone oil. Experiments were performed with 3 Vitreous Models per time point.
Figure 4

Distribution of fluorescein sodium in the Vitreous Model after injection through polyacrylamide gel into silicone oil. Experiments were performed with 3 Vitreous Models per time point.

Based on the results, it is conceivable that the injection into a vitrectomized eye represents a special situation in vitro as well as in vivo. The described effects may also occur in vivo, because the PAAG is adjusted in some of its physicochemical properties to the human vitreous body [3] and both, the SO and the type of injection needle, are in general clinical use. If an intravitreal injection or implant becomes necessary following a vitrectomy with SO insertion, it should be considered that SO may possibly influence the injection process. Consequently, an existing SO bubble may also affect the intravitreal distribution and the pharmacokinetic profile of intravitreal injections [6]. It is assumed that the position of the injection [8] influence the safety and efficacy of the dosage form. Further the nature of the intravitreal area in which the injection is applied, for example a juvenile, liquefied or vitrectomized vitreous body with SO as substitute, may be of great importance [4]. FS is a highly water soluble model drug. However, it may be expected that clinically relevant drugs also may not distribute in the SO. In this case it may be speculated that drug transfer to the retina which should be in direct contact with the SO might also be very limited.

The in vitro distribution behaviour of different dissolved or suspended dosage forms containing clinically relevant drugs such as lipophilic corticosteroids, and the in vivo relevance of the observed effects will have to be examined in further studies.

4 Conclusion

Frequently occurring problems after vitrectomy are inflammatory or neovascularization diseases, which are postoperatively treated with intravitreal injections. To obtain a better understanding of the effectiveness of drugs and dosage forms in vitrectomized eyes, biorelevant in vitro systems can be used for initial estimations. Using the EyeMoS and the modified VM it was possible to simulate the state of the vitreous body after vitrectomy in vitro and to examine the behaviour of SO within a moving model. No mixing of the components or dislocation of SO was observed during a time period of 72 h. The first outcomes in terms of a simulated vitrectomized vitreous body indicated the importance of SO to the initial distribution of FS, based on different injection techniques. After injecting directly into the PAAG, an injection channel was formed, in which the FS was initially distributed. An intended application through the PAAG into the SO resulted in a distribution of the model substance along the interface of the SO and the PAAG. In contrast to the different initial location of FS, the resulting distribution of FS after several hours was comparable in both cases. Almost no FS was detected within the SO but nearly the entire amount within the PAAG. Further studies, in vitro as well as in vivo, are necessary to gain detailed information about pharmacokinetics within a vitrectomized vitreous body.

Acknowledgement

The authors thank Julia Röhm for her technical assistance.

Author’s Statement

Research funding: Financial support by the German Ministry of Education and Research (BMBF) within “Response” is gratefully acknowledged. Conflict of interest: Authors state no conflict of interest. Material and Methods: Informed consent: Informed consent is not applicable. Ethical approval: The conducted research is not related to either human or animal use.

References

[1] Cibis PA, Becker B, Okun E, Canaan S. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol. 1962;68:590–9.10.1001/archopht.1962.00960030594005Search in Google Scholar PubMed

[2] Smiddy WE, Flynn HW. Vitrectomy in the management of diabetic retinopathy. Surv Ophthalmol. 1999;43:491–507.10.1016/S0039-6257(99)00036-3Search in Google Scholar

[3] Loch C, Nagel S, Guthoff R, Seidlitz A, Weitschies W. The vitreous model-a new in vitro test method simulating the vitreous body. Biomed Tech (Berl). 2012;57(SI-1 Track-O):281–4.10.1515/bmt-2012-4106Search in Google Scholar PubMed

[4] Loch C, Bogdahn M, Stein S, Nagel S, Guthoff R, Weitschies W, et al. Simulation of drug distribution in the vitreous body after local drug application into intact vitreous body and in progress of posterior vitreous detachment. J Pharm Sci. 2014;103:517–26.10.1002/jps.23808Search in Google Scholar PubMed

[5] Caramoy A, Hagedorn N, Fauser S, Kugler W, GroßT, Kirchhof B. Development of emulsification-resistant silicone oils: can we go beyond 2000 mPas silicone oil? Invest Ophth Vis Science. 2011;52:5432–6.10.1167/iovs.11-7250Search in Google Scholar PubMed

[6] Hillier RJ, Stappler T, Williams RL, Turner GS, Wong D. The impact of axial length on retinal tamponade for gas, silicone oil, and heavy silicone oil, using an in vitro model. Graefes Arch Clin Exp Ophthalmol. 2011;249;671–5.10.1007/s00417-010-1579-3Search in Google Scholar PubMed PubMed Central

[7] Laude A, Tan LE, Wilson CG, Lascaratos G, Elashry M, Aslam T, Dhillon B. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Retin Eye Res. 2010;29:466–75.10.1016/j.preteyeres.2010.04.003Search in Google Scholar PubMed

[8] Friedrich S, Cheng YL, Saville B. Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume. Curr Eye Res. 1997;16:663–9.10.1076/ceyr.16.7.663.5061Search in Google Scholar PubMed

Published Online: 2016-9-30
Published in Print: 2016-9-1

©2016 Anne Seidlitz et al., licensee De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Synthesis and characterization of PIL/pNIPAAm hybrid hydrogels
  2. Novel blood protein based scaffolds for cardiovascular tissue engineering
  3. Cell adhesion and viability of human endothelial cells on electrospun polymer scaffolds
  4. Effects of heat treatment and welding process on superelastic behaviour and microstructure of micro electron beam welded NiTi
  5. Long-term stable modifications of silicone elastomer for improved hemocompatibility
  6. The effect of thermal treatment on the mechanical properties of PLLA tubular specimens
  7. Biocompatible wear-resistant thick ceramic coating
  8. Protection of active implant electronics with organosilicon open air plasma coating for plastic overmolding
  9. Examination of dielectric strength of thin Parylene C films under various conditions
  10. Open air plasma deposited antimicrobial SiOx/TiOx composite films for biomedical applications
  11. Systemic analysis about residual chloroform in PLLA films
  12. A macrophage model of osseointegration
  13. Towards in silico prognosis using big data
  14. Technical concept and evaluation of a novel shoulder simulator with adaptive muscle force generation and free motion
  15. Usability evaluation of a locomotor therapy device considering different strategies
  16. Hypoxia-on-a-chip
  17. Integration of a semi-automatic in-vitro RFA procedure into an experimental setup
  18. Fabrication of MEMS-based 3D-μECoG-MEAs
  19. High speed digital interfacing for a neural data acquisition system
  20. Bionic forceps for the handling of sensitive tissue
  21. Experimental studies on 3D printing of barium titanate ceramics for medical applications
  22. Patient specific root-analogue dental implants – additive manufacturing and finite element analysis
  23. 3D printing – a key technology for tailored biomedical cell culture lab ware
  24. 3D printing of hydrogels in a temperature controlled environment with high spatial resolution
  25. Biocompatibility of photopolymers for additive manufacturing
  26. Biochemical piezoresistive sensors based on pH- and glucose-sensitive hydrogels for medical applications
  27. Novel wireless measurement system of pressure dedicated to in vivo studies
  28. Portable auricular device for real-time swallow and chew detection
  29. Detection of miRNA using a surface plasmon resonance biosensor and antibody amplification
  30. Simulation and evaluation of stimulation scenarios for targeted vestibular nerve excitation
  31. Deep brain stimulation: increasing efficiency by alternative waveforms
  32. Prediction of immediately occurring microsleep events from brain electric signals
  33. Determining cardiac vagal threshold from short term heart rate complexity
  34. Classification of cardiac excitation patterns during atrial fibrillation
  35. An algorithm to automatically determine the cycle length coverage to identify rotational activity during atrial fibrillation – a simulation study
  36. Deriving respiration from high resolution 12-channel-ECG during cycling exercise
  37. Reducing of gradient induced artifacts on the ECG signal during MRI examinations using Wilcoxon filter
  38. Automatic detection and mapping of double potentials in intracardiac electrograms
  39. Modeling the pelvic region for non-invasive pelvic intraoperative neuromonitoring
  40. Postprocessing algorithm for automated analysis of pelvic intraoperative neuromonitoring signals
  41. Best practice: surgeon driven application in pelvic operations
  42. Vasomotor assessment by camera-based photoplethysmography
  43. Classification of morphologic changes in photoplethysmographic waveforms
  44. Novel computation of pulse transit time from multi-channel PPG signals by wavelet transform
  45. Efficient design of FIR filter based low-pass differentiators for biomedical signal processing
  46. Nonlinear causal influences assessed by mutual compression entropy
  47. Comparative study of methods for solving the correspondence problem in EMD applications
  48. fNIRS for future use in auditory diagnostics
  49. Semi-automated detection of fractional shortening in zebrafish embryo heart videos
  50. Blood pressure measurement on the cheek
  51. Derivation of the respiratory rate from directly and indirectly measured respiratory signals using autocorrelation
  52. Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder
  53. An automatic systolic peak detector of blood pressure waveforms using 4th order cumulants
  54. Real-time QRS detection using integrated variance for ECG gated cardiac MRI
  55. Preprocessing of unipolar signals acquired by a novel intracardiac mapping system
  56. In-vitro experiments to characterize ventricular electromechanics
  57. Continuous non-invasive monitoring of blood pressure in the operating room: a cuffless optical technology at the fingertip
  58. Application of microwave sensor technology in cardiovascular disease for plaque detection
  59. Artificial blood circulatory and special Ultrasound Doppler probes for detecting and sizing gaseous embolism
  60. Detection of microsleep events in a car driving simulation study using electrocardiographic features
  61. A method to determine the kink resistance of stents and stent delivery systems according to international standards
  62. Comparison of stented bifurcation and straight vessel 3D-simulation with a prior simulated velocity profile inlet
  63. Transient Euler-Lagrange/DEM simulation of stent thrombosis
  64. Automated control of the laser welding process of heart valve scaffolds
  65. Automation of a test bench for accessing the bendability of electrospun vascular grafts
  66. Influence of storage conditions on the release of growth factors in platelet-rich blood derivatives
  67. Cryopreservation of cells using defined serum-free cryoprotective agents
  68. New bioreactor vessel for tissue engineering of human nasal septal chondrocytes
  69. Determination of the membrane hydraulic permeability of MSCs
  70. Climate retainment in carbon dioxide incubators
  71. Multiple factors influencing OR ventilation system effectiveness
  72. Evaluation of an app-based stress protocol
  73. Medication process in Styrian hospitals
  74. Control tower to surgical theater
  75. Development of a skull phantom for the assessment of implant X-ray visibility
  76. Surgical navigation with QR codes
  77. Investigation of the pressure gradient of embolic protection devices
  78. Computer assistance in femoral derotation osteotomy: a bottom-up approach
  79. Automatic depth scanning system for 3D infrared thermography
  80. A service for monitoring the quality of intraoperative cone beam CT images
  81. Resectoscope with an easy to use twist mechanism for improved handling
  82. In vitro simulation of distribution processes following intramuscular injection
  83. Adjusting inkjet printhead parameters to deposit drugs into micro-sized reservoirs
  84. A flexible standalone system with integrated sensor feedback for multi-pad electrode FES of the hand
  85. Smart control for functional electrical stimulation with optimal pulse intensity
  86. Tactile display on the remaining hand for unilateral hand amputees
  87. Effects of sustained electrical stimulation on spasticity assessed by the pendulum test
  88. An improved tracking framework for ultrasound probe localization in image-guided radiosurgery
  89. Improvement of a subviral particle tracker by the use of a LAP-Kalman-algorithm
  90. Learning discriminative classification models for grading anal intraepithelial neoplasia
  91. Regularization of EIT reconstruction based on multi-scales wavelet transforms
  92. Assessing MRI susceptibility artefact through an indicator of image distortion
  93. EyeGuidance – a computer controlled system to guide eye movements
  94. A framework for feedback-based segmentation of 3D image stacks
  95. Doppler optical coherence tomography as a promising tool for detecting fluid in the human middle ear
  96. 3D Local in vivo Environment (LivE) imaging for single cell protein analysis of bone tissue
  97. Inside-Out access strategy using new trans-vascular catheter approach
  98. US/MRI fusion with new optical tracking and marker approach for interventional procedures inside the MRI suite
  99. Impact of different registration methods in MEG source analysis
  100. 3D segmentation of thyroid ultrasound images using active contours
  101. Designing a compact MRI motion phantom
  102. Cerebral cortex classification by conditional random fields applied to intraoperative thermal imaging
  103. Classification of indirect immunofluorescence images using thresholded local binary count features
  104. Analysis of muscle fatigue conditions using time-frequency images and GLCM features
  105. Numerical evaluation of image parameters of ETR-1
  106. Fabrication of a compliant phantom of the human aortic arch for use in Particle Image Velocimetry (PIV) experimentation
  107. Effect of the number of electrodes on the reconstructed lung shape in electrical impedance tomography
  108. Hardware dependencies of GPU-accelerated beamformer performances for microwave breast cancer detection
  109. Computer assisted assessment of progressing osteoradionecrosis of the jaw for clinical diagnosis and treatment
  110. Evaluation of reconstruction parameters of electrical impedance tomography on aorta detection during saline bolus injection
  111. Evaluation of open-source software for the lung segmentation
  112. Automatic determination of lung features of CF patients in CT scans
  113. Image analysis of self-organized multicellular patterns
  114. Effect of key parameters on synthesis of superparamagnetic nanoparticles (SPIONs)
  115. Radiopacity assessment of neurovascular implants
  116. Development of a desiccant based dielectric for monitoring humidity conditions in miniaturized hermetic implantable packages
  117. Development of an artifact-free aneurysm clip
  118. Enhancing the regeneration of bone defects by alkalizing the peri-implant zone – an in vitro approach
  119. Rapid prototyping of replica knee implants for in vitro testing
  120. Protecting ultra- and hyperhydrophilic implant surfaces in dry state from loss of wettability
  121. Advanced wettability analysis of implant surfaces
  122. Patient-specific hip prostheses designed by surgeons
  123. Plasma treatment on novel carbon fiber reinforced PEEK cages to enhance bioactivity
  124. Wear of a total intervertebral disc prosthesis
  125. Digital health and digital biomarkers – enabling value chains on health data
  126. Usability in the lifecycle of medical software development
  127. Influence of different test gases in a non-destructive 100% quality control system for medical devices
  128. Device development guided by user satisfaction survey on auricular vagus nerve stimulation
  129. Empirical assessment of the time course of innovation in biomedical engineering: first results of a comparative approach
  130. Effect of left atrial hypertrophy on P-wave morphology in a computational model
  131. Simulation of intracardiac electrograms around acute ablation lesions
  132. Parametrization of activation based cardiac electrophysiology models using bidomain model simulations
  133. Assessment of nasal resistance using computational fluid dynamics
  134. Resistance in a non-linear autoregressive model of pulmonary mechanics
  135. Inspiratory and expiratory elastance in a non-linear autoregressive model of pulmonary mechanics
  136. Determination of regional lung function in cystic fibrosis using electrical impedance tomography
  137. Development of parietal bone surrogates for parietal graft lift training
  138. Numerical simulation of mechanically stimulated bone remodelling
  139. Conversion of engineering stresses to Cauchy stresses in tensile and compression tests of thermoplastic polymers
  140. Numerical examinations of simplified spondylodesis models concerning energy absorption in magnetic resonance imaging
  141. Principle study on the signal connection at transabdominal fetal pulse oximetry
  142. Influence of Siluron® insertion on model drug distribution in the simulated vitreous body
  143. Evaluating different approaches to identify a three parameter gas exchange model
  144. Effects of fibrosis on the extracellular potential based on 3D reconstructions from histological sections of heart tissue
  145. From imaging to hemodynamics – how reconstruction kernels influence the blood flow predictions in intracranial aneurysms
  146. Flow optimised design of a novel point-of-care diagnostic device for the detection of disease specific biomarkers
  147. Improved FPGA controlled artificial vascular system for plethysmographic measurements
  148. Minimally spaced electrode positions for multi-functional chest sensors: ECG and respiratory signal estimation
  149. Automated detection of alveolar arches for nasoalveolar molding in cleft lip and palate treatment
  150. Control scheme selection in human-machine- interfaces by analysis of activity signals
  151. Event-based sampling for reducing communication load in realtime human motion analysis by wireless inertial sensor networks
  152. Automatic pairing of inertial sensors to lower limb segments – a plug-and-play approach
  153. Contactless respiratory monitoring system for magnetic resonance imaging applications using a laser range sensor
  154. Interactive monitoring system for visual respiratory biofeedback
  155. Development of a low-cost senor based aid for visually impaired people
  156. Patient assistive system for the shoulder joint
  157. A passive beating heart setup for interventional cardiology training
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cdbme-2016-0145/html
Scroll to top button